FRAXA Clinical Trial Grant supports scientists studying people with Fragile X syndrome, prioritizing trials of disease-modifying treatments to advance practical therapies and ultimately a cure.
Curative Therapies Grant supports scientists worldwide researching curative and disease-modifying therapies for Fragile X syndrome, with the goal of bringing practical treatments into medical practice.
The General Research Grant supports Friedreich’s ataxia investigators in basic research, drug development, and clinical research to advance shared resources, treatments, and a cure.
The SMA Foundation Research Funding program supports projects that accelerate late-stage translational research or clinical trials for new SMA therapeutics.
Genmab Research Grant Advancing Innovation in Ovarian and Endometrial Cancer supports researchers studying folate receptor alpha expression during cancer progression to guide treatment and patient stratification.
Clinical Trial Grant - Cannonball Kids' cancer Foundation supports researchers developing innovative pediatric cancer trials to expand treatment options, improve quality of life, and relieve symptoms.